S2

Supplementary Figures and Tables
Electronic Supplementary Material (ESI) for Medicinal Chemistry Communications This journal is © The Royal Society of Chemistry 2013
General Procedure for the Synthesis of Bis-dimethylaminopyridine Compounds 1,12-Dibromododecane (0.5 mmol, 164 mg) was dissolved in 2-butanone (10 ml) and to that, 4-dimethylaminopyridine (1 mmol, 122 mg) was added. The reaction mixture was stirred for 3 hours at 110 o C, at which time a white precipitate formed. The precipitate was filtered and washed with 2-butanone (3 x 10 ml) and then diethyl ether (2 x 15 ml) before being dried in vacuo to give the desired product as a white solid (270 mg, 94 % yield). 
Molecular modelling
All calculations were performed at Imperial College High Performance Computing cluster. Ligands were drawn in ChemDraw and imported into Maestro (version 9.2.112, Schrodinger Inc.) and prepared using the LigPrep and Epik (pH 7±2) and the OPLS2005 force field. The protein was imported from the PDB-database (3G15.pdb). Chain A was used throughout the study and the Protein Preparation Wizard was used to remove water molecules, to add hydrogens, hydrogen bonding network optimisation and finally for a restrained energy minimisation. For some dockings two water molecules close to the biding site of hemicholinium that connects Asp306, Asn345 and Glu349 and Arg444 were kept, as well as one water molecule that is involved in bridging hydrogen bonding between the carboxylate of Glu206 and N7 of ADP. Docking grids were constructed from the resulting proteins using the grid generator in GLIDE. The box was placed around hemicholinium and ADP Cell culture and growth inhibition assay HCT-116 colon cancer cells (ATCC) were cultured in RPMI-1640 (Invitrogen) supplemented with 10% foetal calf serum (Lonza), glutamine, penicillin and streptomycin (all Invitrogen). A549 lung cancer cells (ATCC) were maintained in DMEM (Invitrogen) supplemented with 10% foetal calf serum, glutamine, penicillin and streptomycin. St-T1b cells were maintained in DMEM/F12 (Invitrogen) supplemented with 10% foetal calf serum, glutamine, penicillin and streptomycin. Cell lines were incubated at 37°C in a humidified atmosphere containing 5% CO 2 . Half-maximal growth inhibitory concentrations (GI 50 ) were determined using sulforhodamine B (SRB) assay as described elsewhere. 3 In brief, cells were seeded in 96-wells plates and after 24 hours treated in six replicates with medium or 9 different concentrations of inhibitor and incubated for additional 72 hours. Cells were fixed with 10% trichloroacetic acid and stained with 0.4% sulforhodamine B in 1% acetic acid. The stained protein was solubilised in 10 mM Tris (all from Sigma-Aldrich) and optical densities measured at 540 nm using a Multiskan EX spectrophotometer (Thermo Scientific). Growth inhibition curves were plotted as percentage of control cells and GI 50 determined by fitting a sigmoidal curve with variable slope by least squares (ordinary) fitting method in GraphPad Prism version 5.01.
Whole-cell choline kinase activity assay
Inhibitor-dependent reduction of choline kinase activity in whole cells was determined in HCT-116 cells by monitoring the decrease of phosphocholine formation following a modified Bligh and Dyer extraction described elsewhere. 4 In brief, HCT-116 cells were seeded in 6-well plates and treated with 0.16, 0.8, 4, 20 and 100 µM inhibitor for 1 hour and pulsed with 1 μCi [ 3 H]-choline chloride (PerkinElmer) at 0.5 μCi/mL for an additional hour. Cells were washed 3 times in cold PBS and 750 μL of methanol/chloroform (2:1; both from SigmaAldrich) added. The solubilised cytosolic content was transferred into microcentrifuge tubes and 200 μL H 2 O added. Samples were centrifuged for 10 minutes and 750 μL supernatant transferred to fresh microcentrifuge
